This bill authorizes $74 million annually for fiscal years 2026 and 2027 to restore U.S. funding for the United Nations Population Fund (UNFPA), directly supporting its global reproductive health programs. It specifically funds UNFPA's work to end preventable maternal deaths, address unmet contraceptive needs, prevent gender-based violence, and combat harmful practices like female genital mutilation and child marriage across 150+ countries. The funding applies to UNFPA's core operations in humanitarian crises (e.g., Yemen, Afghanistan, Sudan) and excludes programs in China. This would reverse the 2025 funding halt that already caused health center closures and service disruptions for millions of women and girls.
SRES 533 is a non-binding Senate resolution condemning white supremacy, hate, and antisemitism, with specific focus on the promotion of these ideologies by white supremacist Nick Fuentes and his platforming by Tucker Carlson. It highlights Fuentes' Holocaust denial, antisemitic conspiracy theories (like the "Great Replacement" myth), and use of dog whistles, while criticizing Carlson for hosting Fuentes without challenge and Heritage Foundation's Kevin Roberts for defending such views. The resolution urges all elected officials and leaders to reject these ideologies whenever they occur, and affirms condemnation of Nazism and the Holocaust. As a formal expression of Senate opinion, it does not create new laws but serves as a public stance against harmful rhetoric.
HRES 929 is a House resolution condemning the U.S. President's pardon of former Honduran President Juan Orlando Hernández, who was convicted in a U.S. court for leading a decades-long drug trafficking conspiracy. The resolution reaffirms U.S. commitment to partner with Honduras on counter-narcotics efforts and democratic cooperation, regardless of the outcome of Honduras' November 30, 2025, election. It states the pardon undermines U.S. credibility in anti-corruption and counter-narcotics work, emboldens criminal networks, and signals that political influence can override the rule of law. The resolution urges continued U.S. support for security, economic development, and anti-corruption measures in Honduras.
The PBM Price Transparency and Accountability Act requires pharmacy benefit managers (PBMs) to be more transparent about drug pricing and ensure accurate payments to pharmacies. It establishes national average drug acquisition cost benchmarks for Medicaid, prohibits PBMs from keeping excessive profits through "spread pricing," and mandates detailed reporting of drug pricing, rebates, and fees. The bill affects Medicaid programs, Medicare Part D plans, and the PBMs that negotiate drug prices on behalf of insurers. It includes enforcement mechanisms like civil penalties for non-compliance and requires PBMs to report detailed pricing information to the Secretary of Health and Human Services.
The Restoring Patient Protections and Affordability Act of 2025 extends enhanced premium tax credits through 2028, making health insurance more affordable for lower- and middle-income individuals. It extends the 2026 open enrollment period through May 1, 2026, and restores funding for navigator programs that help people enroll in health insurance plans. The bill requires health insurance issuers to notify enrollees about changes to premium assistance and establishes $1,000 daily penalties for failing to comply with these notification requirements. Additionally, it limits surprise premium increases for people with household incomes below 400% of the poverty line and prevents premium spikes for those with ACA or employer coverage. These changes directly affect millions of people enrolled in health insurance plans through the Affordable Care Act marketplaces.
The HUSTLE Act creates tax-advantaged investment accounts for student athletes to save income from name, image, and likeness (NIL) deals. Eligible student athletes at participating colleges can contribute NIL earnings (like endorsements and social media content) to these accounts, which are tax-exempt for the athlete. Distributions before graduation are taxed as ordinary income, but distributions after graduation or transfer qualify for lower long-term capital gains tax rates. The accounts have annual contribution limits based on the gift tax exclusion and require management by banks or approved entities. The bill also includes new rules for sports agents, such as a 5% fee cap on endorsement contracts and registration requirements.
The SAFE Chips Act of 2025 requires U.S. exporters to obtain government licenses before sending advanced computer chips to "foreign adversary countries" (including China, Hong Kong, and Macau) or to entities owned by such countries. It defines "advanced integrated circuits" using specific technical standards, such as high processing power (e.g., 4,800+ performance points) or bandwidth (e.g., 4,100+ gigabytes per second), excluding chips designed for data centers. The bill mandates license denials for these exports and allows the Commerce Secretary to update technical definitions after 30 months, with required Congressional briefings on national security impacts. This directly affects chip manufacturers and companies exporting to specified regions, imposing strict controls on advanced semiconductor trade.
The PBM Disclosure Act clarifies that pharmacy benefit managers (PBMs) and third-party administrators (TPAs) must disclose both direct and indirect compensation they receive for managing pharmacy benefits in employer-sponsored health plans. This requirement directly affects PBMs and TPAs that provide pharmacy benefit management services to health plans. The bill mandates the Department of Labor to issue regulations within 180 days of enactment, which will apply to health plan years beginning six months after publication. The law explicitly clarifies an existing ERISA disclosure rule without creating new requirements.
S 3379 (EARLY Benefits for Workers Act) allows states to use up to 20% of their unemployment grant funds (or $3 million) to provide job training and support services to workers *immediately* after they file for unemployment benefits, rather than waiting for later stages of their claim. This directly affects unemployed workers filing initial claims for regular unemployment benefits, enabling faster access to reemployment help. States cannot deny benefits solely because a worker didn’t use these early services during the initial claim period. If a worker later loses eligibility, states keep the grant funds spent on the early services and aren’t penalized for providing them. The bill changes how states administer unemployment grant funds to speed up job support access.
HR 6425 requires the FBI to create a working group within 90 days, including 18 federal agencies like the FTC and CFPB, to develop a National Strategy for Combating Scams. The strategy must establish a common scam definition, coordinate data collection across agencies, improve public complaint reporting (including for people with disabilities), and enhance private-sector collaboration to prevent scams. It mandates the strategy be submitted to Congress and published publicly within one year, with updates every five years. This bill directly affects federal agencies' coordination efforts but does not create new laws or directly impact citizens beyond improving how the government addresses scams.
The STOP Scams Against Seniors Act directs federal Byrne funds to create elder justice task forces focused on preventing and investigating financial scams targeting seniors aged 60 and older. These task forces must coordinate with local law enforcement, prosecutors, and federal agencies like the FBI and FTC to address fraud. Grantees must report detailed data on cases opened, resolved, victims supported, scam types, and signs of organized crime, with the Attorney General submitting an annual summary to Congress. The bill directly affects seniors vulnerable to financial exploitation and the agencies implementing these task forces.
The Freedom to Heal Act of 2025 creates a new federal registration process for physicians to directly administer Schedule I investigational drugs under the "Right to Try" framework. It requires physicians to apply to the Attorney General with evidence of state compliance, manufacturer agreements, and training, and limits the amount of drugs they may possess based on approved applications. The bill mandates the Attorney General to issue interim rules within 240 days and final rules within two years covering drug delivery, storage, recordkeeping, and registration management. This affects physicians treating eligible patients with Schedule I drugs under federal Right to Try provisions, not the patients themselves.
